Clinical trial
Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered…
NCT00189943 · Bavarian Nordic, Industry · Completed
Key facts
| NCT number | NCT00189943 |
|---|---|
| Title | Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects |
| Official title | Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects |
| Lead sponsor | Bavarian Nordic, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Smallpox |
| Intervention type | Biological |
| Interventions | MVA-BN |
| Enrollment | 90 |
| Start date | Apr 1, 2001 |
| Completion | Jul 1, 2003 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 19, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: